Intended for healthcare professionals

News

Rivaroxaban: Lancet opens investigation into anticlotting drug trial after BMJ report

BMJ 2022; 379 doi: https://doi.org/10.1136/bmj.o3071 (Published 30 December 2022) Cite this as: BMJ 2022;379:o3071